Other highlights from the June 6 JNCI

Aspirin Use, But Not NSAIDS, Associated with Reduced Cancer Risk

In a prospective study, aspirin use was associated with lower risk of cancer incidence and mortality, particularly among former and non-smokers.

The effectiveness of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing cancer is unclear, and the relationship is complicated further when smoking history is considered.

Aditya Bardia, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues analyzed data from the Iowa Womens Health Study on aspirin and nonaspirin NSAID use, cancer incidence and mortality, and smoking history.

Aspirin use was associated with decreased risk of cancer incidence and mortality, as well as heart disease mortality, compared to people who didnt take aspirin. The association was stronger among former and never smokers than current smokers, although the difference was not statistically significant. Nonaspirin NSAID use was not associated with decreased risk.

Aspirin use could potentially prevent approximately 4.7% of the cancer incidence burden, 3.5% of the cancer mortality burden, and 7.6% of the coronary heart disease mortality burden in the population. Although these percentages may seem small, the impact on public health could be important, the authors write.

Contact: Elizabeth Zimmermann, Mayo Clinic, Department of Public Affairs, zimmermann.elizabeth@mayo.edu, (507) 266-0810

Mutations to Integrin 7 Gene May Promote Cancer Development

A protein called integrin 7 suppresses tumor growth and cell migration, and mutations in the integrin 7 gene are identified in various cancers, including prostate and liver cancer.

Integrins are important adhesive molecules in mammalian cells. Integrin 7 appears to be involved in muscle development and in communication between muscle cells and

Contact: Liz Savage
Journal of the National Cancer Institute

Page: 1 2 3

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:

(Date:8/4/2019)... ... 02, 2019 , ... Stay on top of current hot topics through free ... to all webinars is free, so be sure to register today to save your ... http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , August 27 – ...
(Date:8/1/2019)... ... July 31, 2019 , ... Molecular ... launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. ... FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering a ...
(Date:7/24/2019)... ... July 24, 2019 , ... NDA Partners Chairman Carl ... with more than 20 years of experience working in scientific research and FDA-regulated ... as an Expert Consultant. , Dr. Hartzfeld has experience in all aspects of ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... STATE COLLEGE, Pa. (PRWEB) , ... August 13, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment ... of healthcare industry experience to the Board. , Mark McLoughlin will lend his ...
(Date:8/6/2019)... ... 06, 2019 , ... The San Diego Biotechnology Network (SDBN) ... SDBN BUZZ podcast focused on connecting the region’s biotech community and discussing topics ... the region and attract external employers, investors, scientists, and others who wish to ...
(Date:8/4/2019)... (PRWEB) , ... August 02, 2019 , ... Cirtec Medical ... invasive devices, today announced that it has begun construction on a 30,000 sq. ft. ... 15 miles from San Jose. , The facility, which is expected to be ...
(Date:7/19/2019)... ... July 18, 2019 , ... Global precision motion and ... current piezo motion facilities in Lederhose, Germany, increasing their current footprint by half ... assembly production in addition to general office space, a significant increase to its ...
Breaking Biology Technology:
Cached News: